scholarly article | Q13442814 |
P356 | DOI | 10.3109/17453679308994587 |
P698 | PubMed publication ID | 8291408 |
P2093 | author name string | J Keller | |
S A Schmidt | |||
O Kristensen | |||
P Kjaersgaard-Andersen | |||
U Lucht | |||
A Nafei | |||
G Teichert | |||
P433 | issue | 6 | |
P304 | page(s) | 639-642 | |
P577 | publication date | 1993-12-01 | |
P1433 | published in | Acta Orthopaedica | Q10400516 |
P1476 | title | Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties | |
P478 | volume | 64 |
Q33942168 | A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery |
Q40766760 | Biochemical responses in cultured cells following exposure to (89)SrCl(2): potential relevance to the mechanism of action in pain palliation |
Q44242456 | COX-2 selective NSAID decreases bone ingrowth in vivo |
Q35581260 | Cox-2 Selective Inhibitors and Bone |
Q35668938 | Do Nonsteroidal Anti-Inflammatory Drugs Cause Endoprosthetic Loosening? Mid- to Long-Term Follow-Up of 100 Total Hip Arthroplasties after Local NSAID Infiltration |
Q64107138 | Heterotopic Ossification: A Challenging Complication of Total Hip Arthroplasty: Risk Factors, Diagnosis, Prophylaxis, and Treatment |
Q39485664 | Heterotopic bone formation about the hip undergoes endochondral ossification: a rabbit model |
Q47698255 | Indomethacin for 3 days is not effective as prophylaxis for heterotopic ossification after primary total hip arthroplasty |
Q34702475 | Neurogenic heterotopic ossification in spinal cord injury. |
Q24799015 | Nodular osteochondrogenic activity in soft tissue surrounding osteoma in neurogenic para osteo-arthropathy: morphological and immunohistochemical study |
Q24200252 | Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty |
Q24246587 | Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty |
Q33978320 | Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty |
Q28088671 | Nonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis |
Q24235518 | Pharmacological interventions for treating acute heterotopic ossification |
Q24245975 | Pharmacological interventions for treating acute heterotopic ossification |
Q34137773 | Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and disease |
Q35215473 | Prevention of heterotopic ossification after total hip replacement with NSAIDs |
Q46743614 | Short-course indomethacin prevents heterotopic ossification in a high-risk population following total hip arthroplasty |
Q33722361 | Surgical Excision of Heterotopic Ossification Leads to Re-Emergence of Mesenchymal Stem Cell Populations Responsible for Recurrence |
Q70913946 | The effect of low dose diclofenac sodium administered locally on heterotopic bone formation in rats |
Q24673561 | Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach |
Search more.